Chiesi Group Collaborates with Aliada Therapeutics to Develop Enzyme Replacement Therapies for Lysosomal Storage Disorders
Shots: Ref: Chiesi | Image: Chiesi & Aliada Therapeutics| Press Release Related News:- EirGenix Enters ~$152M…
Read article →
Novartis Reports P-III (KALUMA) Trial Data of KLU156 for Uncomplicated Malaria
Shots: Ref: Novartis | Image: Novartis | Press Release Related News:- Novartis Reports Cosentyx P-III trial met 1 & 2…
Read article →
Promega’s OncoMate MSI Dx Analysis System Receives FDA Approval as a Companion Diagnostic
Shots: Ref: Businesswire | Image: Promega | Press Release Related News:- Johnson & Johnson MedTech Launches Shockwave…
Read article →
March Biosciences’ MB-105 Receives the Regenerative Medicine Advanced Therapy Designation for R/R CD5+ T-Cell Lymphoma
Shots: Ref: GlopbeNewsWire| Image: March Biosciences| Press Release Related News:- Neurona Therapeutics’ NRTX-1001…
Read article →
EirGenix Enters ~$152M Licensing Deal with Sandoz to Commercialize EG1206A (Biosimilar, Perjeta)
Shots: Ref: PRnewswire| Image: EirGenix & Sandoz | Press Release Related News:- Minze Health Partners with Medtronic…
Read article →
Top 20 Countries in Health Innovation in 2025
Shots: Introduction In this 2025 edition of Healthcare Innovation Reimagined, PharmaShots presents an in-depth…
Read article →
argenx Receives Health Canada’s Approval for Vyvgart SC to Treat Chronic Inflammatory Demyelinating Polyneuropathy
Shots: Ref: Newswire.CA| Image: Argenx | Press Release Related News:- argenx Reports Topline P-III (ADAPT SERON) Trial…
Read article →
Aqua Medical Receives the US FDA IDE Approval to Initiate Trial for Ablation Procedure to Treat Uncontrolled Type 2 Diabetes
Shots: Ref: PRNewsWire | Image: Aqua Medical | Press Release Related News:- Pulse Biosciences Receives FDA IDE…
Read article →